Article info

Download PDFPDF

Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study
Free
  1. Correspondence to:
    Dr P Lahdenne;
    pekka.lahdenne{at}hus.fi
View Full Text

Citation

Lahdenne P, Vähäsalo P, Honkanen V
Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study

Publication history

  • Accepted July 23, 2002
  • First published March 1, 2003.
Online issue publication 
March 01, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.